The ability to precisely control the composition of nanocrystals, similar to the way organic chemists control the structure of small molecules, remains an important challenge in nanoscience. Rather than dictating nanocrystal size through the nucleation event, growth of nanocrystals through continuous precursor addition would allow fine structural control. Herein, we present a method of growth for indium oxide nanocrystals that relies on the slow addition of an indium carboxylate precursor into hot oleyl alcohol. Nanocrystal size and structure can be governed at a subnanometer scale, and it is possible to precisely control core size over a range of three to at least 22 nm with dispersities as low as 7%. Growth can be stopped and restarted repeatedly without aggregation or passivation. We show that the volume of the nanocrystal core (and thus molecular weight) increases linearly with added monomer and the number of nanocrystals remains constant throughout the growth process, yielding an extremely predictable approach to size control. It is also possible to place metal oxide shells (e.g., Sn-doped In2O3 (ITO)) at various radial positions within the nanocrystal, and we use this approach to synthesize ITO/In2O3 core/shell nanocrystals as well as In2O3/ITO/In2O3 core/shell/shell nanocrystals.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsnano.6b02796 | DOI Listing |
Pharmaceutics
December 2024
Department of Hospital Surgery, Department of Plastic and Reconstructive Surgery, Cosmetology and Cell Technology, Pirogov Russian National Research Medical University (RNRMU), 117997 Moscow, Russia.
Background/objectives: The aim was to study the possibilities of biomedical application of gadolinium oxide nanoparticles (GdO NPs) synthesized under industrial conditions, and evaluate their physicochemical properties, redox activity, biological activity, and safety using different human cell lines.
Methods: The powder of GdO NPs was obtained by a process of thermal decomposition of gadolinium carbonate precipitated from nitrate solution, and was studied using transmission electron microscopy (TEM), X-ray diffraction (XRD), Raman spectroscopy, mass spectrometry, and scanning electron microscopy (SEM) with energy dispersive X-ray analyzer (EDX). The redox activity of different concentrations of GdO NPs was studied by the optical spectroscopy (OS) method in the photochemical degradation process of methylene blue dye upon irradiation with an optical source.
Pharmaceutics
December 2024
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Background/objectives: Crickets are recognized as an alternative source of chitosan. This study aimed to assess the potential of cricket-derived chitosan as a natural source to develop chitosan nanoparticles (CNPs).
Methods: Chitosan were isolated from different cricket species, including , , and .
Pharmaceutics
December 2024
Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830046, China.
Background: The clinical efficacies of anticancer drugs are limited by non-selective toxic effects on healthy tissues and low bioavailability in tumor tissue. Therefore, the development of vehicles that can selectively deliver and release drugs at the tumor site is critical for further improvements in patient survival.
Methods: We prepared a CEC nano-drug delivery system, CEC@ZIF-8, with a zeolite imidazole framework-8 (ZIF-8) as a carrier, which can achieve the response of folate receptor (FR).
Pharmaceutics
November 2024
Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
Lipid nanoparticles (LNPs) have shown promise as a delivery system for nucleic acid-based therapeutics, including DNA, siRNA, and mRNA vaccines. The immune system plays a critical role in the response to these nanocarriers, with innate immune cells initiating an early response and adaptive immune cells mediating a more specific reaction, sometimes leading to potential adverse effects. Recent studies have shown that the innate immune response to LNPs is mediated by Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), which recognize the lipid components of the nanoparticles.
View Article and Find Full Text PDFPharmaceutics
November 2024
Universidad Nacional de Hurlingham (UNAHUR), Secretaría de Investigación, Laboratorio de Nanosistemas de Aplicación Biotecnológica (LANSAB), Hurlingham 1688, Buenos Aires, Argentina.
The aims of this work were to formulate cannabidiol in different lipid carriers for skin delivery after topical application and to study their stability, interaction with the skin, and antibacterial activity. Solid lipid nanoparticles and nanostructured lipid carriers loaded with cannabidiol were prepared and characterized in terms of their physicochemical properties, colloidal stability, protection of the antioxidant capacity of cannabidiol, as well as their retention over time. Skin penetration was assessed using an in vitro model with human skin.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!